The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.

MLA

Caponi, S., et al. “The Good, the Bad and the Ugly: A Tale of MiR-101, MiR-21 and MiR-155 in Pancreatic Intraductal Papillary Mucinous Neoplasms.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 24, no. 3, Mar. 2013, pp. 734–41. EBSCOhost, https://doi.org/10.1093/annonc/mds513.

APA

Caponi, S., Funel, N., Frampton, A. E., Mosca, F., Santarpia, L., Van der Velde, A. G., Jiao, L. R., De Lio, N., Falcone, A., Kazemier, G., Meijer, G. A., Verheul, H. M., Vasile, E., Peters, G. J., Boggi, U., & Giovannetti, E. (2013). The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 24(3), 734–741. https://doi.org/10.1093/annonc/mds513

Chicago

Caponi, S, N Funel, A E Frampton, F Mosca, L Santarpia, A G Van der Velde, L R Jiao, et al. 2013. “The Good, the Bad and the Ugly: A Tale of MiR-101, MiR-21 and MiR-155 in Pancreatic Intraductal Papillary Mucinous Neoplasms.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 24 (3): 734–41. doi:10.1093/annonc/mds513.